BioSpace News Archive

Today, the U.S. Food and Drug Administration (FDA) approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease, a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to be pushed forward and bulge outwards (proptosis).

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the U.S. Food and Drug Administration (FDA) has approved TEPEZZATM (teprotumumab-trbw) for the treatment of Thyroid Eye Disease (TED). TEPEZZA is the first and only FDA-approved medicine for the treatment of TED

Cell>Point announced, based on its sponsored chelator and therapeutic research conducted at the University of Texas M.D. Anderson Cancer Center on Platinum-Oncardia and 177Lu-Oncardia, and the positive results of its lung cancer imaging trials with 99mTc-Oncardia®, that it will be moving forward with these two intra-nuclear therapeutics expanding its focus in theranostic medicine.

More than 130 teams from Genesis HealthCare joined the Alzheimer’s Association’s Walk to End Alzheimer’s® in the fight to end Alzheimer’s disease.

Profound Medical Corp. is pleased to announce that it intends to file a preliminary prospectus supplement to its short form base shelf prospectus dated October 17, 2019 in the United States and Canada relating to a proposed marketed public offering of common shares of the Company.

SI-BONE, Inc., a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced that it has commenced an underwritten public offering of 4,300,000 shares of its common stock.

Cerner Corporation, a global health care technology company, recognizes Cornwall Community Hospital for receiving Canada’s highest level of accreditation through Accreditation Canada’s Qmentum International Accreditation Program.

Vertex Pharmaceuticals Incorporated will report its full-year and fourth-quarter 2019 financial results on Thursday, January 30, 2020 after the financial markets close.

Vyaire Medical, Inc. announced that its Board of Directors has appointed Gaurav Agarwal as Chief Executive Officer, effective immediately.

Washington, DC-based healthcare technology startup Socially Determined announced today that it has closed its Series A investment round, raising a total of $11.1M.